391 related articles for article (PubMed ID: 33922029)
1. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.
Abdullah O; Omran Z; Hosawi S; Hamiche A; Bronner C; Alhosin M
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922029
[TBL] [Abstract][Full Text] [Related]
2. The Potential Role of
Alsanosi S; Sheikh RA; Sonbul S; Altayb HN; Batubara AS; Hosawi S; Al-Sakkaf K; Abdullah O; Omran Z; Alhosin M
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566130
[No Abstract] [Full Text] [Related]
3. Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.
Alhosin M; Omran Z; Zamzami MA; Al-Malki AL; Choudhry H; Mousli M; Bronner C
J Exp Clin Cancer Res; 2016 Nov; 35(1):174. PubMed ID: 27839516
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties.
Alhosin M; Sharif T; Mousli M; Etienne-Selloum N; Fuhrmann G; Schini-Kerth VB; Bronner C
J Exp Clin Cancer Res; 2011 Apr; 30(1):41. PubMed ID: 21496237
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 poly-auto-ubiquitination induced by the anti-cancer drug, thymoquinone, is involved in the DNA repair machinery recruitment.
Almalki NAR; Sabir JSM; Ibrahim A; Alhosin M; Asseri AH; Albiheyri RS; Zari AT; Bahieldin A; Javed A; Mély Y; Hamiche A; Mousli M; Bronner C
Int J Biochem Cell Biol; 2024 Jun; 171():106582. PubMed ID: 38649007
[TBL] [Abstract][Full Text] [Related]
6. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of
Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
[TBL] [Abstract][Full Text] [Related]
8. Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns.
Bronner C; Alhosin M; Hamiche A; Mousli M
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30669400
[TBL] [Abstract][Full Text] [Related]
9. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma.
Colyn L; Bárcena-Varela M; Álvarez-Sola G; Latasa MU; Uriarte I; Santamaría E; Herranz JM; Santos-Laso A; Arechederra M; Ruiz de Gauna M; Aspichueta P; Canale M; Casadei-Gardini A; Francesconi M; Carotti S; Morini S; Nelson LJ; Iraburu MJ; Chen C; Sangro B; Marin JJG; Martinez-Chantar ML; Banales JM; Arnes-Benito R; Huch M; Patino JM; Dar AA; Nosrati M; Oyarzábal J; Prósper F; Urman J; Cubero FJ; Trautwein C; Berasain C; Fernandez-Barrena MG; Avila MA
Hepatology; 2021 Jun; 73(6):2380-2396. PubMed ID: 33222246
[TBL] [Abstract][Full Text] [Related]
10. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.
Unoki M; Brunet J; Mousli M
Biochem Pharmacol; 2009 Nov; 78(10):1279-88. PubMed ID: 19501055
[TBL] [Abstract][Full Text] [Related]
11. Structure-based screening of chemical libraries to identify small molecules that are likely to bind with the SET and RING-associated (SRA) domain of Ubiquitin-like, PHD and Ring Finger-containing 1 (UHRF1).
Patnaik D
BMC Res Notes; 2020 May; 13(1):254. PubMed ID: 32448288
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways.
Alhosin M; Razvi SSI; Sheikh RA; Khan JA; Zamzami MA; Choudhry H
Technol Cancer Res Treat; 2020; 19():1533033820947489. PubMed ID: 32912061
[TBL] [Abstract][Full Text] [Related]
13. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1.
Han J; Chen X; Xu J; Chu L; Li R; Sun N; Jiang Z; Liu H; Ge X; Zheng J; Yang J; Ikezoe T
Int J Med Sci; 2021; 18(15):3437-3451. PubMed ID: 34522170
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms.
Qadi SA; Hassan MA; Sheikh RA; Baothman OA; Zamzami MA; Choudhry H; Al-Malki AL; Albukhari A; Alhosin M
Epigenet Insights; 2019; 12():2516865719839011. PubMed ID: 31058255
[TBL] [Abstract][Full Text] [Related]
16. Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.
Choudhry H; Zamzami MA; Omran Z; Wu W; Mousli M; Bronner C; Alhosin M
Oncol Lett; 2018 Jan; 15(1):3-10. PubMed ID: 29285183
[TBL] [Abstract][Full Text] [Related]
17. The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence.
Jung HJ; Byun HO; Jee BA; Min S; Jeoun UW; Lee YK; Seo Y; Woo HG; Yoon G
J Biol Chem; 2017 Mar; 292(9):3729-3739. PubMed ID: 28100769
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk Between Histone and DNA Methylation Mediates Bone Loss in Hind Limb Unloading.
Li B; Zhao J; Ma J; Chen W; Zhou C; Wei W; Li S; Li G; Xin G; Zhang Y; Liu J; Wang Y; Ma X
J Bone Miner Res; 2021 May; 36(5):956-967. PubMed ID: 33465813
[TBL] [Abstract][Full Text] [Related]
19. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis.
Bronner C; Krifa M; Mousli M
Biochem Pharmacol; 2013 Dec; 86(12):1643-9. PubMed ID: 24134914
[TBL] [Abstract][Full Text] [Related]
20. Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Bárcena-Varela M; Caruso S; Llerena S; Álvarez-Sola G; Uriarte I; Latasa MU; Urtasun R; Rebouissou S; Alvarez L; Jimenez M; Santamaría E; Rodriguez-Ortigosa C; Mazza G; Rombouts K; San José-Eneriz E; Rabal O; Agirre X; Iraburu M; Santos-Laso A; Banales JM; Zucman-Rossi J; Prósper F; Oyarzabal J; Berasain C; Ávila MA; Fernández-Barrena MG
Hepatology; 2019 Feb; 69(2):587-603. PubMed ID: 30014490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
